In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1841 News Items found
In the Lab
MSK cancer researchers Elizabeth Adams, Charles Sawyers, and Rohit Bose
Researchers Unravel the Biology of a Distinct Prostate Cancer Subtype

Mutations in a gene called FOXA1 are responsible for a distinct class of prostate cancer tumors, MSK researchers have found.
Feature
holding hands
Hard Conversations: How to Talk to Your Care Team and Loved Ones about Dying

Follow these guidelines for holding difficult yet important end-of-life conversations.
In the Lab
An illustration of a samurai and a crab.
Ro Versus Musashi: How One Molecule Can Turn Cancer Cells Back to Normal

Researchers identify a compound that appears to eliminate tumor cells in a dish and in mice.
In the Clinic
Doctor with back to camera speaking with smiling girl.
Proton Therapy: A Safer Way to Eliminate Tumors in Kids

Proton therapy offers a way to treat pediatric cancers more safely.
In the Lab
Immune cells surrounding a cancer cell
Checkpoint Challenge: When Releasing Immune Cell Brakes Is Not Enough to Stop Cancer

Scientists have learned that cutting a T cell’s brakes can have unexpected consequences.
Feature
MSK patient Kara Kenny hugging medical oncologist Diane Reidy Lagunes
Coping with Rectal Cancer: A Young Mother’s Story of Determination and Compassion

Learn how MSK is helping a young mother cope with rectal cancer through the Center for Young Onset Colorectal Cancer, the first program in the country devoted to younger adults with this disease.
MSK-ACCESS Receives New York State Approval for New Molecular Assay

Memorial Sloan Kettering Cancer Center (MSK) today announced that the New York State Department of Health has issued approval for a new molecular assay, Analysis of Circulating cfDNA to Evaluate Somatic Status (MSK-ACCESS).  MSK-ACCESS was developed within the Marie-Josee and Henry R. Kravis Center for Molecular Oncology (CMO) and the test has been clinically validated and implemented by members of MSK’s Molecular Diagnostics Service.
In the Lab
Two clusters of colored blobs with a diagram in the middle
Computational “Hive Mind” Helps Scientists Solve an Enzyme’s Cryptic Movements

The breakthrough gives an unprecedented look at the varied and shifting poses of a protein in action.
Roundup
People milling about at the 2019 ASCO meeting
Highlights from ASCO 2019: A Low-Fat Diet and Breast Cancer Risk, Targeted Therapy for Salivary Gland Tumors, and More

Read about a few of the MSK studies being presented at the 2019 American Society of Clinical Oncology's annual meeting.
Roundup
Crowd shot at ASCO 2019
Highlights from ASCO 2019: Progress in Treating Cancer in Children

MSK Kids doctors report advances in treating pediatric cancers at the 2019 meeting of the American Society of Clinical Oncology.